Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients
Conditions: Breast Cancer; Alpha Lipoic Acid; Paclitaxel; Neurologic Disorder; Chemotherapy Interventions: Drug: Alpha Lipoic Acid 600 MG Oral Capsule Sponsors: Ain Shams University; Dar EL Salam Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials
Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Interventions: Other: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test Sponsors: Henan Cancer Hospital; Kingbio Medical (Beijing) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials
Cervical Cancer Susceptible Population Classification
Conditions: Cervical Cancer Susceptible Population Classification Interventions: Genetic: PCR and sequence Sponsors: Anhui Provincial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials
Risk of Malignancy in Endemic Long Standing Nodular Goitres: a Prospective Cohort Study
Conditions: Incidence of Thyroid Cancer in Long Standing MNG Interventions: Diagnostic Test: Histopathology Sponsors: University of Khartoum; Sudan Medical Specialization Board Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer; Stage IV Breast Cancer AJCC V7 Interventions: Behavioral: ACCESS Supportive Care; Behavioral: Phone sessions Sponsors: Icahn School of Medicine at Mount Sinai; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2024 Category: Research Source Type: clinical trials
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: Conversion or neoadjuvant therapy. Sponsors: Guangxi Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Conditions: Urothelial Carcinoma Interventions: Drug: BL-B01D1; Drug: PD-1 Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study
Conditions: Adenocarcinoma Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Evaluation of the PreCursor-M+ ® in CIN2
Conditions: Cervical Intraepithelial Neoplasia Grade 2 Sponsors: European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Prehabilitation in Oncological Patients Undergoing Major Gastrointestinal Surgery (PROGRESS)
Conditions: Oncological Patients; Major Surgery Interventions: Behavioral: Multimodal prehabilitation Program Sponsors: Universit à Vita-Salute San Raffaele Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Conditions: Pancreatic Cancer Interventions: Drug: nimotuzumab; Drug: AG chemotherapy Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
A Multicentre Prospective Cohort Study: Effect of (Neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
Conditions: Young Breast Cancer Patient; Lipids; Anti-tumour Drug Therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer ：a Multicentre Retrospective Study
Conditions: Early-Stage Rectal Cancer; Robotic Surgery; Natural Orifice Specimen Extraction Surgery Interventions: Procedure: R-NOSES group; Procedure: R-TSES group Sponsors: Taiyuan Li Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Conditions: Nanoliposomal Irinotecan; Cadonilimab; Oxaliplatin; Capecitabine; First-Line; Advanced Cancer; Pancreatic Adenocarcinoma; Drug Use Interventions: Drug: Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation
Conditions: Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations Interventions: Other: no intervention Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
